Literature DB >> 26833913

Expression of functional cannabinoid CB2 receptor in VTA dopamine neurons in rats.

Hai-Ying Zhang1,2, Ming Gao3, Hui Shen2, Guo-Hua Bi1, Hong-Ju Yang1, Qing-Rong Liu1, Jie Wu3, Eliot L Gardner1, Antonello Bonci2,4,5, Zheng-Xiong Xi1.   

Abstract

We have recently reported the expression of functional cannabinoid CB2 receptors (CB2 Rs) in midbrain dopamine (DA) neurons in mice. However, little is known whether CB2 Rs are similarly expressed in rat brain because significant species differences in CB2 R structures and expression are found. In situ hybridization and immunohistochemical assays detected CB2 gene and receptors in DA neurons of the ventral tegmental area (VTA), which was up-regulated in cocaine self-administration rats. Electrophysiological studies demonstrated that activation of CB2 Rs by JWH133 inhibited VTA DA neuronal firing in single dissociated neurons. Systemic administration of JWH133 failed to alter, while local administration of JWH133 into the nucleus accumbens inhibited cocaine-enhanced extracellular DA and i.v. cocaine self-administration. This effect was blocked by AM630, a selective CB2 R antagonist. These data suggest that CB2 Rs are expressed in VTA DA neurons and functionally modulate DA neuronal activities and cocaine self-administration behavior in rats.
© 2016 Society for the Study of Addiction.

Entities:  

Keywords:  CB2 receptor; JWH133; cannabinoid; cocaine; dopamine; self-administration

Mesh:

Substances:

Year:  2016        PMID: 26833913      PMCID: PMC4969232          DOI: 10.1111/adb.12367

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  58 in total

Review 1.  CB2: a cannabinoid receptor with an identity crisis.

Authors:  Brady K Atwood; Ken Mackie
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

2.  Species differences in cannabinoid receptor 2 (CNR2 gene): identification of novel human and rodent CB2 isoforms, differential tissue expression and regulation by cannabinoid receptor ligands.

Authors:  Q-R Liu; C-H Pan; A Hishimoto; C-Y Li; Z-X Xi; A Llorente-Berzal; M-P Viveros; H Ishiguro; T Arinami; E S Onaivi; G R Uhl
Journal:  Genes Brain Behav       Date:  2009-06-03       Impact factor: 3.449

3.  Synthesis and preliminary evaluation of a new fluorine-18 labelled triazine derivative for PET imaging of cannabinoid CB2 receptor.

Authors:  Laurent Hortala; Joëlle Arnaud; Pascale Roux; Didier Oustric; Laurent Boulu; Florence Oury-Donat; Patrick Avenet; Thomas Rooney; David Alagille; Olivier Barret; Gilles Tamagnan; Francis Barth
Journal:  Bioorg Med Chem Lett       Date:  2013-11-20       Impact factor: 2.823

Review 4.  The endocannabinoid system and the brain.

Authors:  Raphael Mechoulam; Linda A Parker
Journal:  Annu Rev Psychol       Date:  2012-07-12       Impact factor: 24.137

Review 5.  Endocannabinoids and traumatic brain injury.

Authors:  Esther Shohami; Ayelet Cohen-Yeshurun; Lital Magid; Merav Algali; Raphael Mechoulam
Journal:  Br J Pharmacol       Date:  2011-08       Impact factor: 8.739

6.  Expression of the cannabinoid CB2 receptor in the rat cerebellum: an immunohistochemical study.

Authors:  John C Ashton; Deborah Friberg; Cynthia L Darlington; Paul F Smith
Journal:  Neurosci Lett       Date:  2005-12-13       Impact factor: 3.046

7.  The effects of cannabinoid CB1, CB2 and vanilloid TRPV1 receptor antagonists on cocaine addictive behavior in rats.

Authors:  Przemysław Adamczyk; Joanna Miszkiel; Andrew C McCreary; Małgorzata Filip; Mariusz Papp; Edmund Przegaliński
Journal:  Brain Res       Date:  2012-01-20       Impact factor: 3.252

8.  Molecular characterization of a peripheral receptor for cannabinoids.

Authors:  S Munro; K L Thomas; M Abu-Shaar
Journal:  Nature       Date:  1993-09-02       Impact factor: 49.962

9.  Brain cannabinoid CB₂ receptors modulate cocaine's actions in mice.

Authors:  Zheng-Xiong Xi; Xiao-Qing Peng; Xia Li; Rui Song; Hai-Ying Zhang; Qing-Rong Liu; Hong-Ju Yang; Guo-Hua Bi; Jie Li; Eliot L Gardner
Journal:  Nat Neurosci       Date:  2011-07-24       Impact factor: 24.884

10.  Pharmacological blockade of either cannabinoid CB1 or CB2 receptors prevents both cocaine-induced conditioned locomotion and cocaine-induced reduction of cell proliferation in the hippocampus of adult male rat.

Authors:  Eduardo Blanco-Calvo; Patricia Rivera; Sergio Arrabal; Antonio Vargas; Francisco Javier Pavón; Antonia Serrano; Estela Castilla-Ortega; Pablo Galeano; Leticia Rubio; Juan Suárez; Fernando Rodriguez de Fonseca
Journal:  Front Integr Neurosci       Date:  2014-01-08
View more
  50 in total

1.  Different receptor mechanisms underlying phytocannabinoid- versus synthetic cannabinoid-induced tetrad effects: Opposite roles of CB1 /CB2 versus GPR55 receptors.

Authors:  Xiao-Fei Wang; Ewa Galaj; Guo-Hua Bi; Cindy Zhang; Yi He; Jia Zhan; Michael H Bauman; Eliot L Gardner; Zheng-Xiong Xi
Journal:  Br J Pharmacol       Date:  2020-02-11       Impact factor: 8.739

2.  Endocannabinoids exert CB1 receptor-mediated neuroprotective effects in models of neuronal damage induced by HIV-1 Tat protein.

Authors:  Changqing Xu; Douglas J Hermes; Blessing Nwanguma; Ian R Jacobs; Kenneth Mackie; Somnath Mukhopadhyay; Aron H Lichtman; Bogna Ignatowska-Jankowska; Sylvia Fitting
Journal:  Mol Cell Neurosci       Date:  2017-07-19       Impact factor: 4.314

3.  Neuroprotective effects of fatty acid amide hydrolase catabolic enzyme inhibition in a HIV-1 Tat model of neuroAIDS.

Authors:  Douglas J Hermes; Changqing Xu; Justin L Poklis; Micah J Niphakis; Benjamin F Cravatt; Ken Mackie; Aron H Lichtman; Bogna M Ignatowska-Jankowska; Sylvia Fitting
Journal:  Neuropharmacology       Date:  2018-08-13       Impact factor: 5.250

4.  Cannabinoid CB1 and CB2 receptor mechanisms underlie cannabis reward and aversion in rats.

Authors:  Krista J Spiller; Guo-Hua Bi; Yi He; Ewa Galaj; Eliot L Gardner; Zheng-Xiong Xi
Journal:  Br J Pharmacol       Date:  2019-04-03       Impact factor: 8.739

Review 5.  Drug-Induced Alterations of Endocannabinoid-Mediated Plasticity in Brain Reward Regions.

Authors:  Natalie E Zlebnik; Joseph F Cheer
Journal:  J Neurosci       Date:  2016-10-05       Impact factor: 6.167

6.  Synthetic peripherally-restricted cannabinoid suppresses chemotherapy-induced peripheral neuropathy pain symptoms by CB1 receptor activation.

Authors:  Yatendra Mulpuri; Vincent N Marty; Joseph J Munier; Ken Mackie; Brian L Schmidt; Herbert H Seltzman; Igor Spigelman
Journal:  Neuropharmacology       Date:  2018-07-05       Impact factor: 5.250

7.  Δ8 -Tetrahydrocannabivarin has potent anti-nicotine effects in several rodent models of nicotine dependence.

Authors:  Zheng-Xiong Xi; Pretal Muldoon; Xiao-Fei Wang; Guo-Hua Bi; M Imad Damaj; Aron H Lichtman; Roger G Pertwee; Eliot L Gardner
Journal:  Br J Pharmacol       Date:  2019-10-28       Impact factor: 8.739

Review 8.  Progress in brain cannabinoid CB2 receptor research: From genes to behavior.

Authors:  Chloe J Jordan; Zheng-Xiong Xi
Journal:  Neurosci Biobehav Rev       Date:  2019-01-03       Impact factor: 8.989

Review 9.  Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders.

Authors:  Ewa Galaj; Zheng-Xiong Xi
Journal:  CNS Drugs       Date:  2019-10       Impact factor: 5.749

10.  The cannabinoid CB2 receptor agonist LY2828360 synergizes with morphine to suppress neuropathic nociception and attenuates morphine reward and physical dependence.

Authors:  Vishakh Iyer; Richard A Slivicki; Ana C Thomaz; Jonathon D Crystal; Ken Mackie; Andrea G Hohmann
Journal:  Eur J Pharmacol       Date:  2020-09-05       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.